IPO Profile

CardioVascular BioTherapeutics
1700 West Horizon Ridge Parkway, Suite 100, Henderson, Nevada 89012
Tel: 714-368-1520
Web:
Ticker: CVBT
Stock Exchange: Nasdaq
Shares Issued: 2,000,000.00
Price Offered: $0.00
Amount Raised: $20,000,000.00

Underwriters:
First Dunbar Securities





Company Description:
We are a biopharmaceutical company focused on developing a new drug for the treatment of cardiovascular disease. Our drug candidate, called Cardio Vascu-Grow�, is designed to facilitate the growth of new blood vessels in the heart and surrounding vascular system. A report by the American Heart Association, Heart Disease and Stroke Statistics�2003 Update indicates that over 38% of all deaths in the United States are caused by coronary artery disease.